FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023507218> ?p ?o ?g. }

• W2023507218 endingPage "e29728" @default.
• W2023507218 startingPage "e29728" @default.
• W2023507218 abstract "CD44 is a major cellular receptor for hyaluronic acids. The stem structure of CD44 encoded by ten normal exons can be enlarged by ten variant exons (v1-v10) by alternative splicing. We have succeeded in preparing MV5 fully human IgM and its class-switched GV5 IgG monoclonal antibody (mAb) recognizing the extracellular domain of a CD44R1 isoform that contains the inserted region coded by variant (v8, v9 and v10) exons and is expressed on the surface of various human epithelial cancer cells.We demonstrated the growth inhibition of human cancer xenografts by a GV5 IgG mAb reshaped from an MV5 IgM. The epitope recognized by MV5 and GV5 was identified to a v8-coding region by the analysis of mAb binding to various recombinant CD44 proteins by enzyme-linked immunosorbent assay. GV5 showed preferential reactivity against various malignant human cells versus normal human cells assessed by flow cytometry and immunohistological analysis. When ME180 human uterine cervix carcinoma cells were subcutaneously inoculated to athymic mice with GV5, significant inhibition of tumor formation was observed. Furthermore, intraperitoneal injections of GV5markedly inhibited the growth of visible established tumors from HSC-3 human larynx carcinoma cells that had been subcutaneously transplanted one week before the first treatment with GV5. From in vitro experiments, antibody-dependent cellular cytotoxicity and internalization of CD44R1 seemed to be possible mechanisms for in vivo anti-tumor activity by GV5.CD44R1 is an excellent molecular target for mAb therapy of cancer, possibly superior to molecules targeted by existing therapeutic mAb, such as Trastuzumab and Cetuximab recognizing human epidermal growth factor receptor family." @default.
• W2023507218 created "2016-06-24" @default.
• W2023507218 creator A5010927861 @default.
• W2023507218 creator A5012278399 @default.
• W2023507218 creator A5018669075 @default.
• W2023507218 creator A5019577667 @default.
• W2023507218 creator A5023988830 @default.
• W2023507218 creator A5024631337 @default.
• W2023507218 creator A5027334433 @default.
• W2023507218 creator A5027446935 @default.
• W2023507218 creator A5028153411 @default.
• W2023507218 creator A5028505068 @default.
• W2023507218 creator A5030552361 @default.
• W2023507218 creator A5031181557 @default.
• W2023507218 creator A5031614450 @default.
• W2023507218 creator A5036634489 @default.
• W2023507218 creator A5039137137 @default.
• W2023507218 creator A5039542779 @default.
• W2023507218 creator A5040437196 @default.
• W2023507218 creator A5045747449 @default.
• W2023507218 creator A5051821952 @default.
• W2023507218 creator A5055086561 @default.
• W2023507218 creator A5064866374 @default.
• W2023507218 creator A5070071795 @default.
• W2023507218 creator A5074635039 @default.
• W2023507218 creator A5080226044 @default.
• W2023507218 date "2012-01-17" @default.
• W2023507218 modified "2023-09-30" @default.
• W2023507218 title "Anti-Tumor Effect against Human Cancer Xenografts by a Fully Human Monoclonal Antibody to a Variant 8-Epitope of CD44R1 Expressed on Cancer Stem Cells" @default.
• W2023507218 cites W1555371735 @default.
• W2023507218 cites W1979421565 @default.
• W2023507218 cites W1980973383 @default.
• W2023507218 cites W1985585224 @default.
• W2023507218 cites W1986433888 @default.
• W2023507218 cites W1999356404 @default.
• W2023507218 cites W2006297891 @default.
• W2023507218 cites W2018755526 @default.
• W2023507218 cites W2020084538 @default.
• W2023507218 cites W2023377449 @default.
• W2023507218 cites W2023427658 @default.
• W2023507218 cites W2023643379 @default.
• W2023507218 cites W2031742143 @default.
• W2023507218 cites W2037632318 @default.
• W2023507218 cites W2041399911 @default.
• W2023507218 cites W2048503292 @default.
• W2023507218 cites W2054114326 @default.
• W2023507218 cites W2061142243 @default.
• W2023507218 cites W2065748630 @default.
• W2023507218 cites W2071167287 @default.
• W2023507218 cites W2081447858 @default.
• W2023507218 cites W2088729159 @default.
• W2023507218 cites W2094238516 @default.
• W2023507218 cites W2098435943 @default.
• W2023507218 cites W2101939391 @default.
• W2023507218 cites W2104940816 @default.
• W2023507218 cites W2121921687 @default.
• W2023507218 cites W2126333578 @default.
• W2023507218 cites W2128012941 @default.
• W2023507218 cites W2129658989 @default.
• W2023507218 cites W2130227585 @default.
• W2023507218 cites W2135231064 @default.
• W2023507218 cites W2137333233 @default.
• W2023507218 cites W2142564546 @default.
• W2023507218 cites W2153382986 @default.
• W2023507218 cites W2158863975 @default.
• W2023507218 cites W2159459001 @default.
• W2023507218 cites W2318605753 @default.
• W2023507218 cites W60759546 @default.
• W2023507218 doi "https://doi.org/10.1371/journal.pone.0029728" @default.
• W2023507218 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3260170" @default.
• W2023507218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22272243" @default.
• W2023507218 hasPublicationYear "2012" @default.
• W2023507218 type Work @default.
• W2023507218 sameAs 2023507218 @default.
• W2023507218 citedByCount "32" @default.
• W2023507218 countsByYear W20235072182012 @default.
• W2023507218 countsByYear W20235072182013 @default.
• W2023507218 countsByYear W20235072182014 @default.
• W2023507218 countsByYear W20235072182015 @default.
• W2023507218 countsByYear W20235072182016 @default.
• W2023507218 countsByYear W20235072182017 @default.
• W2023507218 countsByYear W20235072182018 @default.
• W2023507218 countsByYear W20235072182019 @default.
• W2023507218 countsByYear W20235072182021 @default.
• W2023507218 countsByYear W20235072182022 @default.
• W2023507218 countsByYear W20235072182023 @default.
• W2023507218 crossrefType "journal-article" @default.
• W2023507218 hasAuthorship W2023507218A5010927861 @default.
• W2023507218 hasAuthorship W2023507218A5012278399 @default.
• W2023507218 hasAuthorship W2023507218A5018669075 @default.
• W2023507218 hasAuthorship W2023507218A5019577667 @default.
• W2023507218 hasAuthorship W2023507218A5023988830 @default.
• W2023507218 hasAuthorship W2023507218A5024631337 @default.
• W2023507218 hasAuthorship W2023507218A5027334433 @default.
• W2023507218 hasAuthorship W2023507218A5027446935 @default.
• W2023507218 hasAuthorship W2023507218A5028153411 @default.
• W2023507218 hasAuthorship W2023507218A5028505068 @default.
• W2023507218 hasAuthorship W2023507218A5030552361 @default.

• next